Bitcoin halving
What does that mean?
$2.79T
Total marketcap
$122.89B
Total volume
BTC 49.95%     ETH 15.31%
Dominance

Tango Therapeutics TNGX Stock

7.77 USD {{ price }} 0.844157% {{change_pct}}%
Exchange
NasdaqGM
Market Cap
828.67M USD
LOW - HIGH [24H]
7.63 - 7.99 USD
VOLUME [24H]
253.07K USD
{{ volume }}
P/E Ratio
0
Earnings per share
-1.08 USD

Tango Therapeutics Price Chart

Tango Therapeutics TNGX Financial and Trading Overview

Tango Therapeutics stock price 7.77 USD
Previous Close 3.51 USD
Open 3.5 USD
Bid 0 USD x 800
Ask 0 USD x 900
Day's Range 3.36 - 3.66 USD
52 Week Range 2.47 - 8.56 USD
Volume 81.72K USD
Avg. Volume 224.64K USD
Market Cap 319.15M USD
Beta (5Y Monthly) 1.63773
PE Ratio (TTM) N/A
EPS (TTM) -1.08 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 15.2 USD

TNGX Valuation Measures

Enterprise Value 18.04M USD
Trailing P/E N/A
Forward P/E -2.375
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 12.83366
Price/Book (mrq) 1.4013975
Enterprise Value/Revenue 0.725
Enterprise Value/EBITDA -0.158

Trading Information

Tango Therapeutics Stock Price History

Beta (5Y Monthly) 1.63773
52-Week Change -23.67%
S&P500 52-Week Change 20.43%
52 Week High 8.56 USD
52 Week Low 2.47 USD
50-Day Moving Average 3.6 USD
200-Day Moving Average 5.38 USD

TNGX Share Statistics

Avg. Volume (3 month) 224.64K USD
Avg. Daily Volume (10-Days) 402.21K USD
Shares Outstanding 88.41M
Float 43.74M
Short Ratio 9.82
% Held by Insiders 15.32%
% Held by Institutions 78.30%
Shares Short 1.84M
Short % of Float 4.19%
Short % of Shares Outstanding 2.08%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 0%
Operating Margin (ttm) -466.37%
Gross Margin 0%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -16.56%
Return on Equity (ttm) -40.53%

Income Statement

Revenue (ttm) 24.87M USD
Revenue Per Share (ttm) 0.28 USD
Quarterly Revenue Growth (yoy) 0.10%
Gross Profit (ttm) -81046000 USD
EBITDA -114098000 USD
Net Income Avi to Common (ttm) -110976000 USD
Diluted EPS (ttm) -1.22
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 333.64M USD
Total Cash Per Share (mrq) 3.77 USD
Total Debt (mrq) 41.37M USD
Total Debt/Equity (mrq) 18.21 USD
Current Ratio (mrq) 6.391
Book Value Per Share (mrq) 2.576

Cash Flow Statement

Operating Cash Flow (ttm) -114322000 USD
Levered Free Cash Flow (ttm) -47807248 USD

Profile of Tango Therapeutics

Country United States
State MA
City Boston
Address 201 Brookline Avenue
ZIP 02215
Phone 857 320-4900
Website https://www.tangotx.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 110

Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company also develops TNG462, an oral small molecule methylthioadenosine-cooperative inhibitor for the treatment for cancers with methylthioadenosine phosphorylase deletions; TNG260, a co-repressor of repressor element-1 silencing transcription -selective inhibitor; TNG348, an ubiquitin-specific protease 1 inhibitor to treat patients with BRCA1 or BRCA2-mutant cancers; and Target 3 for STK11-mutant cancers. Tango Therapeutics, Inc. has a strategic collaboration with Gilead Sciences, Inc. for the discovery, development, and commercialization of a pipeline of therapies for patients with cancer. The company was founded in 2017 and is headquartered in Boston, Massachusetts.

Q&A For Tango Therapeutics Stock

What is a current TNGX stock price?

Tango Therapeutics TNGX stock price today per share is 7.77 USD.

How to purchase Tango Therapeutics stock?

You can buy TNGX shares on the NasdaqGM exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Tango Therapeutics?

The stock symbol or ticker of Tango Therapeutics is TNGX.

Which industry does the Tango Therapeutics company belong to?

The Tango Therapeutics industry is Biotechnology.

How many shares does Tango Therapeutics have in circulation?

The max supply of Tango Therapeutics shares is 106.72M.

What is Tango Therapeutics Price to Earnings Ratio (PE Ratio)?

Tango Therapeutics PE Ratio is now.

What was Tango Therapeutics earnings per share over the trailing 12 months (TTM)?

Tango Therapeutics EPS is -1.08 USD over the trailing 12 months.

Which sector does the Tango Therapeutics company belong to?

The Tango Therapeutics sector is Healthcare.

Tango Therapeutics TNGX included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.name }} {{ item.symbol }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
NASDAQ Composite IXIC 16380.6 USD
-0.12
2.74B USD 16347.38 USD 16420.92 USD 2.74B USD
Stlmt ID NASDAQ Biotechnology NBX 4604.4 USD
-2.98
4555.41 USD 4917.8 USD
NASDAQ Global Market Composite NQGM 2281.87 USD
+0.43
2277.12 USD 2296.84 USD
NASDAQ Biotechnology NBI 4429.59 USD
-0.37
4426.59 USD 4461.88 USD
NASDAQ HealthCare IXHC 1012 USD
-0.02
1011.36 USD 1017.55 USD